MEDICAL COMMUNITY

Suggestions for headache care at coronavirus time

Suggestions for headache care at coronavirus time by  The European Headache Federation (EHF) and The European Migraine & Headache Alliance (EMHA) Coronavirus pandemia has completely changed health systems’ organization and priorities. Headache service are heavily affected by those changes. They have been suspended or reduced, to limit social contacts. Patients also would rather stay at home. …

Suggestions for headache care at coronavirus time Read More »

European Migraine Day of Action with MEPS in the European Parliament

Each year, September 12th is the European Migraine Day of Action. Today, EMHA’s President and Executive Director have been invited by MEP Esteban Gonzalez Pons and MEP Dolors Montserrat to the European Parliament to discuss about how to better help the affected ones to give light to the disease and how to improve the life …

European Migraine Day of Action with MEPS in the European Parliament Read More »

New drugs, decades in the making, are providing relief for migraines.

Nancy Baum Lipsitz remembers the night the pain began. She’d had a glass of white wine with a friend and went to bed with a terrible headache. The next day, she still felt horrible, the beginning of what she called a “rolling tide” of near constant migraines and lower level headaches. For three years she …

New drugs, decades in the making, are providing relief for migraines. Read More »

“Green light” to Lilly’s monoclonal antibody to migraine

Eli Lilly announces that the European Commission (EC) has approved the commercialization of galcanezumab ( Emgality ) as a prophylactic treatment of migraine in adults suffering from at least four days of migraine per month . Galcanezumab is a humanized monoclonal antibody that binds to the peptide related to the calcite gene (CGRP, for its acronym in English) associated with episodes …

“Green light” to Lilly’s monoclonal antibody to migraine Read More »

Migraine Atlas by AEMICE

AEMICE together with Universidad de Sevilla (Seville University) and Novartis and a scientific committee of expert neurologists has created the Migraine Atlas 2018 which reflects the real situation of the 4.5 million people who suffer from migraine in Spain! Unlike other studies “Migraine Atlas” includes the patients and also their families perspective about their condition, the healthcare …

Migraine Atlas by AEMICE Read More »

Master on Headache Disorders

Copenhagen University is now offering a Master on Headache Disorders. It´s a continuing professional development programme for healthcare professionals. The programme of the Master on Headache Disorders requires a minimum of 6 individual visits to Copenhagen, Denmark over a two-year period: Modules 1 to 4 are organized with an e-learning self-study period followed by one week …

Master on Headache Disorders Read More »

Scroll to Top